Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Publication Information:
      BMC
    • Publication Date:
      2019
    • Collection:
      Directory of Open Access Journals: DOAJ Articles
    • Abstract:
      Background Self-titration of blood pressure (BP) medications and lifestyle modifications are effective and safe strategies to lower BP. We assessed the feasibility of implementing a pharmacist-guided, patient-driven self-titration protocol and standardized dietary counseling to improve BP in the chronic kidney disease (CKD) clinic. Methods Adult patients seen in the CKD clinic were identified via registry screening. Inclusion criteria were as follows: a diagnosis of hypertension, average of the last 3 office BP > 150/90 mmHg, and prescribed 3 or fewer BP medications. Patients with severe hypertension were excluded. BP goals were established and patients were referred to the clinical pharmacist who provided them a BP cuff, a BP medication titration plan (based on home BP monitoring), and dietary education. The following outcomes were evaluated: appeal of the program to patients identified by the registry, patient adherence to the protocol and 6-month office BP, and provider attitudes and acceptance of the protocol. Results Seventeen patients enrolled in the pilot, the majority recruited via clinic schedule screening. Eleven of the 17 patients completed a 6-month office follow-up visit. Three of the 11 patients met their pre-specified office BP goal. There was, however, significant improvement in 6-month office systolic and diastolic BP. Twelve of 17 patients were adherent to entering home BP in EMR. Provider satisfaction with the protocol was high. Conclusion Our preliminary data suggest that patient-driven self-titration of BP medications is feasible and well received by providers. Future studies are needed to validate these findings and to evaluate the safety and efficacy of this approach.
    • ISSN:
      2055-5784
    • Relation:
      http://link.springer.com/article/10.1186/s40814-019-0410-0; https://doaj.org/toc/2055-5784; https://doaj.org/article/74dda88a314d4fb2b9b98ca06e1f5656
    • Accession Number:
      10.1186/s40814-019-0410-0
    • Online Access:
      https://doi.org/10.1186/s40814-019-0410-0
      https://doaj.org/article/74dda88a314d4fb2b9b98ca06e1f5656
    • Accession Number:
      edsbas.62B7675F